Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qingqing Guo

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
Ebiomedicine|February 17, 2020
Corrigendum to 'Osteoblastic PLEKHO1 contributes to joint inflammation in rheumatoid arthritis' [EBioMedicine 41 (2019) 538-555]Xiaojuan He, Jin Liu, Chao Liang, et al.
Ebiomedicine|March 3, 2019
Osteoblastic PLEKHO1 contributes to joint inflammation in rheumatoid arthritisXiaojuan He, Jin Liu, Chao Liang, et al.
Molecular Cell|December 17, 2021
Rapid characterization of spike variants via mammalian cell surface displayKamyab Javanmardi, Chia-Wei Chou, Cynthia I Terrace, et al.
Advanced Healthcare Materials|June 23, 2025
Pyrrolidinium Fullerenes as YTHDF1 Inhibitors for Targeted Tumor TherapyXin Wang, Weixin Zhang, Jiawei Huo, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
Ebiomedicine|February 17, 2020
Corrigendum to 'Osteoblastic PLEKHO1 contributes to joint inflammation in rheumatoid arthritis' [EBioMedicine 41 (2019) 538-555]Xiaojuan He, Jin Liu, Chao Liang, et al.
Ebiomedicine|March 3, 2019
Osteoblastic PLEKHO1 contributes to joint inflammation in rheumatoid arthritisXiaojuan He, Jin Liu, Chao Liang, et al.
Molecular Cell|December 17, 2021
Rapid characterization of spike variants via mammalian cell surface displayKamyab Javanmardi, Chia-Wei Chou, Cynthia I Terrace, et al.
Advanced Healthcare Materials|June 23, 2025
Pyrrolidinium Fullerenes as YTHDF1 Inhibitors for Targeted Tumor TherapyXin Wang, Weixin Zhang, Jiawei Huo, et al.
Pageof 10